149 related articles for article (PubMed ID: 36284039)
21. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
22. STAT6 expression in glioblastoma promotes invasive growth.
Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA
BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677
[TBL] [Abstract][Full Text] [Related]
24. Hotspot mutant p53-R273H inhibits KLF6 expression to promote cell migration and tumor metastasis.
Sun S; Chen H; Sun L; Wang M; Wu X; Xiao ZJ
Cell Death Dis; 2020 Jul; 11(7):595. PubMed ID: 32733026
[TBL] [Abstract][Full Text] [Related]
25. ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1.
Ma H; Gollahon LS
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821020
[TBL] [Abstract][Full Text] [Related]
26. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
Samant RS; Clark DW; Fillmore RA; Cicek M; Metge BJ; Chandramouli KH; Chambers AF; Casey G; Welch DR; Shevde LA
Mol Cancer; 2007 Jan; 6():6. PubMed ID: 17227585
[TBL] [Abstract][Full Text] [Related]
28. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
29. DNAJA1 promotes proliferation and metastasis of breast cancer by activating mutant P53/NF-κB pathway.
Wu J; Yang Q; Zhu Y; Xia T; Yi L; Wang J; Ren X
Pathol Res Pract; 2023 Dec; 252():154921. PubMed ID: 37977037
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.
Edmonds MD; Hurst DR; Vaidya KS; Stafford LJ; Chen D; Welch DR
Int J Cancer; 2009 Oct; 125(8):1778-85. PubMed ID: 19585508
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.
Dixit D; Sharma V; Ghosh S; Mehta VS; Sen E
Cell Death Dis; 2012 Feb; 3(2):e271. PubMed ID: 22318540
[TBL] [Abstract][Full Text] [Related]
33. BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells.
Mei P; Bai J; Shi M; Liu Q; Li Z; Fan Y; Zheng J
PLoS One; 2014; 9(5):e98544. PubMed ID: 24879377
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer metastasis suppressor gene, breast cancer metastasis suppressor 1, may be associated with clinicopathological features of breast cancer.
Lin L; Cai M; Dai Y; Zheng Z; Jiang F; Shi L; Pan Y; Song HB
J Cancer Res Ther; 2018 Jun; 14(Supplement):S368-S374. PubMed ID: 29970691
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion.
Zheng Y; Yang W; Aldape K; He J; Lu Z
J Biol Chem; 2013 Nov; 288(44):31488-95. PubMed ID: 24045955
[TBL] [Abstract][Full Text] [Related]
36. Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
Hashemi ZS; Forouzandeh Moghadam M; Khalili S; Ghavami M; Salimi F; Sadroddiny E
Breast Cancer; 2019 Mar; 26(2):215-228. PubMed ID: 30284194
[TBL] [Abstract][Full Text] [Related]
37. Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.
England B; Huang T; Karsy M
Tumour Biol; 2013 Aug; 34(4):2063-74. PubMed ID: 23737287
[TBL] [Abstract][Full Text] [Related]
38. The role of immunohistochemistry in predicting behavior of astrocytic tumors.
Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628
[TBL] [Abstract][Full Text] [Related]
39. Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.
Cui RX; Liu N; He QM; Li WF; Huang BJ; Sun Y; Tang LL; Chen M; Jiang N; Chen L; Yun JP; Zeng J; Guo Y; Wang HY; Ma J
BMC Cancer; 2012 Aug; 12():376. PubMed ID: 22931099
[TBL] [Abstract][Full Text] [Related]
40. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]